Suchergebnisse - "Reyes, Roxana"

PubPharm (31)

11

Time-Dependent COVID-19 Mortality in Patients With Cancer : An Updated Analysis of the OnCovid Registry

enthalten in: JAMA oncology | 2022

von OnCovid Study Group | Pinato, D. | Patel, M. | +78

12

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

13

Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations

enthalten in: World journal of clinical oncology | 2021

von Muñoz-Guglielmetti, D. | Sanchez-Lorente, D. | Reyes, R. | +15

14

A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC

enthalten in: Cancers | 2021

von Aya, F. | Benegas, M. | Viñolas, N. | +5

15

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer : a European study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pinato, D. | Scotti, L. | Gennari, A. | +67

CommentIn: Lancet Oncol. 2021 Jun;22(6):755. - PMID 33894836

16

Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC) : The pluie study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Epaillard, N. | Benitez, J. | Gorria, T. | +10

17

EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non-Small Cell Lung Cancer

enthalten in: Cancers | 2021

von Martin-Deleon, R. | Teixido, C. | Lucena, C. | +14

18

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection : the OnCovid Inflammatory Score

enthalten in: Journal for immunotherapy of cancer | 2021

von Dettorre, G. | Dolly, S. | Loizidou, A. | +59

ErratumIn: J Immunother Cancer. 2021 Jun;9(6):. - PMID 34135105

19

Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis : experience from routine laboratory practice

enthalten in: Journal of thoracic disease | 2021

von González de Aledo-Castillo, J. | Arcocha, A. | Victoria, I. | +8

20

Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer

enthalten in: Molecular oncology | 2021

von Aguado, C. | Teixido, C. | Román, R. | +29